OGN
NYSE · Pharmaceuticals
Organon & Co
$6.03
-0.24 (-3.83%)
Performance
1D
—
1W
—
1M
—
3M
-16.02%
6M
-40.94%
1Y
-59.04%
YTD
-16.71%
Open$6.29
Previous Close$6.27
Day High$6.30
Day Low$6.02
52W High$15.88
52W Low$6.16
Volume—
Avg Volume3.18M
Market Cap1.63B
P/E Ratio8.73
EPS$0.72
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$7.87
Below
SMA 200
$8.85
Below
RSI (14)
32.1
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Sell
16 analysts
Price Target
+1,399.2% upside
Current
$6.03
$6.03
Target
$90.40
$90.40
$73.92
$90.40 avg
$125.40
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.19B | 6.17B | 515.23M |
| Net Income | 186.08M | 167.09M | 144.40M |
| Profit Margin | 3.0% | 2.9% | 28.0% |
| EBITDA | 1.09B | 1.04B | 186.20M |
| Free Cash Flow | — | — | 113.95M |
| Rev Growth | +0.2% | +0.2% | +11.5% |
| Debt/Equity | 11.49 | 11.49 | 0.71 |
Dividend
Dividend Yield1.28%
Annual Dividend$0.34
Payout Ratio47.1%
Frequencyquarterly
Ex-DividendMar 29, 2026
Pay DateApr 18, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |